Search Results 1931-1940 of 17281 for chlamydiachlamydia

1. Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients with Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma - Mayo Clinic

   RATIONALE: Everolimus may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as rituximab, can ...

2. Exploring Reproductive Aging: A Women's Health Study - Mayo Clinic

   The purpose of this study is to review of electronic medical records (EMR) to examine comprehensive clinical data to improve and personalize healthcare for ...

3. Wearable Technology for Health Monitoring in a Urological Patient Population. - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

4. A Study to Learn More about How Individuals Process Specific Medications Based on Their Genes in Patients with Gastrointestinal Disorders - Mayo Clinic

   About this study · To evaluate the pharmacogenomic profile (PGx) by genotyping 22 genes, including the CYP2D6 genotype, in patients with functional GI disorders.

5. A Study Comparing BMS-986504 In Combination With Nab-paclitaxel And Gemcitabine Versus Placebo In Combination With Nab-paclitaxel And Gemcitabine In Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30) - Mayo Clinic

   Clinical Trials · A Study Comparing BMS-986504 In Combination With Nab-paclitaxel And Gemcitabine Versus Placebo In Combination With Nab-paclitaxel And ...

6. American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis - Mayo Clinic

   About this study. Vasculitis is group of diseases where inflammation of blood vessels is the common feature. Patients typically present with fever, fatigue, ...

7. A Study to Assess Monoclonal B-cell Lymphocytosis in Individuals with Chronic Hepatitis C - Mayo Clinic

   To determine the prevalence of MBL in patients with chronic hepatitis C who are to begin therapy with DAA, and compare with clinic controls who are seen in the ...

8. Cediranib Maleate and Selumetinib in Treating Patients With Solid Malignancies - Mayo Clinic

   Cediranib maleate and selumetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Cediranib maleate may also stop the ...

9. Oral Pacritinib Versus Best Available Therapy to Treat Myelofibrosis With Thrombocytopenia - Mayo Clinic

   About this study. The primary hypothesis of the study is that treatment with either once-daily or twice-daily pacritinib results in a greater proportion of ...

10. Study to Evaluate the Safety and Effectiveness of BMS-986036 in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Cirrhosis - Mayo Clinic

    The purpose of this study is to evaluate the safety and effectiveness of BMS-986036 in adults with nonalcoholic steatophepatitis (NASH) and compensated liver ...